KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis.
KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis.
复制标题
DOI:
10.1371/journal.ppat.1007175
复制
发表时间:
2018-07
期刊:
影响因子:
6.7
通讯作者:
Mesri EA
中科院分区:
文献类型:
--
作者:
Cavallin LE;Ma Q;Naipauer J;Gupta S;Kurian M;Locatelli P;Romanelli P;Nadji M;Goldschmidt-Clermont PJ;Mesri EA
Kaposi’s sarcoma (KS) herpesvirus (KSHV) causes KS, an angiogenic AIDS-associated spindle-cell neoplasm, by activating host oncogenic signaling cascades through autocrine and paracrine mechanisms. Tyrosine kinase receptor (RTK) proteomic arrays, identified PDGF receptor-alpha (PDGFRA) as the predominantly-activated RTK in KSHV-induced mouse KS-tumors. We show that: 1) KSHV lytic replication and the vGPCR can activate PDGFRA through upregulation of its ligands PDGFA/B, which increase c-myc, VEGF and KSHV gene expression in infected cells 2) KSHV infected spindle cells of most AIDS-KS lesions display robust phospho-PDGFRA staining 3) blocking PDGFRA-signaling with N-acetyl-cysteine, RTK-inhibitors Imatinib and Sunitinib, or dominant-negative PDGFRA inhibits tumorigenesis 4) PDGFRA D842V activating-mutation confers resistance to Imatinib in mouse-KS tumorigenesis. Our data show that KSHV usurps sarcomagenic PDGFRA signaling to drive KS. This and the fact that PDGFRA drives non-viral sarcomas highlights the importance for KSHV-induced ligand-mediated activation of PDGFRA in KS sarcomagenesis and shows that this oncogenic axis could be successfully blocked to impede KS tumor growth. Signaling mimicry is a key mechanism whereby oncoviruses can usurp host-regulatory pathways leading to acquisition of tissue-specific cancer hallmarks. A critical question in the KS field is the identification of this host pathways activated by KSHV that could provide novel insights on KSHV-pathobiology, elucidating new druggable pathways. Here we show that KSHV lytic replication as well as the KSHV-oncogene vGPCR activates PDGFRA signaling through upregulation of its ligands PDGFA/B, and that blocking of PDGFRA signaling is anti-tumorigenic. This indicates that approaches that fully and stably inhibit PDGFR-signaling could lead to successful treatments for KS, validating this receptor-ligand signaling-axis as a therapeutic target.
登录
查看更多内容
影响因子:
45.3
作者:
Heinrich, MC;Corless, CL;Fletcher, JA
通讯作者:
Fletcher, JA
影响因子:
15.9
作者:
Ganem, Don
通讯作者:
Ganem, Don
影响因子:
6.4
作者:
Hosseinipour, Mina C.;Sweet, Kristen M.;Dittmer, Dirk P.
通讯作者:
Dittmer, Dirk P.
DOI:
10.1097/qad.0000000000000682
发表时间:
2015-06-19
期刊:
AIDS (London, England)
影响因子:
--
作者:
Labo N;Miley W;Benson CA;Campbell TB;Whitby D
通讯作者:
Whitby D
影响因子:
20.3
作者:
Liu, Ren;Li, Xiuqing;Gill, Parkash S.
通讯作者:
Gill, Parkash S.